Strides Pharma Science Ltd Financial Overview
Strides Pharma Science Ltd's market cap is currently ₹89.40B. The company's EPS TTM is ₹14.4; its P/E ratio is 22.49; and it has a dividend yield of 0.41%. Strides Pharma Science Ltd is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
